In vitro anti-hepatitis B virus effect of Hypericum perforatum L.

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 30, Issue 1, 2010, Pages 98-102

  Pang, Ran ^a   Tao, Junyan ^b   Zhang, Shuling ^a   Zhu, Jiang ^c   Yue, Xin ^d   Zhao, Lei ^a   Ye, Pian ^a   Zhu, Ying ^d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^c Chemistry Industry Institute of Jiangxi   (China)

^d WUHAN UNIVERSITY   (China)

Author keywords

HBeAg; HBsAg; HBV DNA; HBV promoter; Hepatitis B virus; Hypericum perforatum L.

Indexed keywords

ANTIVIRUS AGENT; PLANT EXTRACT; VIRUS DNA;

ARTICLE; CELL STRAIN HEPG2; CHEMISTRY; DRUG EFFECT; GENETIC TRANSCRIPTION; HEPATITIS B VIRUS; HUMAN; HYPERICUM; PROMOTER REGION;

ANTIVIRAL AGENTS; DNA, VIRAL; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; HYPERICUM; PLANT EXTRACTS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 77149131831     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-010-0118-0     Document Type: Article

References (27)

1. K. Savikin S. Dobric V. Tadic, et al. 2007 Antiinflammatory activity of ethanol extracts of Hypericum perforatum L., H. barbatum Jacq., H. hirsutum L., H. richeri Vill. and H. androsaemum L. in rats Phytother Res 21 2 176 180 10.1002/ptr.2041 17143926 (Pubitemid 46255084)
2. G. Roscetti O. Franzese A. Comandini, et al. 2004 Cytotoxic activity of Hypericum perforatum L. on K562 erythroleukemic cells: differential effects between methanolic extract and hypericin Phytother Res 18 1 66 72 10.1002/ptr.1369 1:CAS:528:DC%2BD2cXhvFehsrs%3D 14750204 (Pubitemid 38173506)
3. J.M. Jacobson L. Feinman L. Liebes, et al. 2001 Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection Antimicrob Agents Chemother 45 2 517 524 10.1128/AAC.45.2.517-524.2001 1:CAS:528:DC%2BD3MXmsVGksg%3D%3D 11158749 (Pubitemid 32105289)
4. P. Valentao M. Carvalho E. Fernandes, et al. 2004 Protective activity of Hypericum androsaemum infusion against tert-butyl hydroperoxide-induced oxidative damage in isolated rat hepatocytes J Ethnopharmacol 92 1 79 84 10.1016/j.jep.2004.02.004 15099852 (Pubitemid 38510267)
5. M. Usai B. Leggio S. Grappi, et al. 2003 Hypericum perforatum subspecies angustifolium shows a protective activity on the consequences of unavoidable stress exposure at lower doses than Hypericum perforatum perforatum Pharmacopsychiatry 36 6 283 287 10.1055/s-2003-45114 1:CAS:528: DC%2BD2cXhtVSiurw%3D 14663651 (Pubitemid 38085145)
6. P. Ye S.L. Zhang L. Zhao, et al. 2009 Tea polyphenols exerts anti-hepatitis B virus effects in a stably HBV-transfected cell line J Huazhong Univ Sci Technol Med Sci 29 2 169 172 1:CAS:528:DC%2BD1MXltVyltr4%3D 19399398
7. N. Moolla M. Kew P. Arbuthnot 2002 Regulatory elements of hepatitis B virus transcription J Viral Hepat 9 5 323 331 10.1046/j.1365-2893.2002.00381.x 12225325 (Pubitemid 35056582)
8. B.H. Choi G.T. Park H.M. Rho 1999 Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter J Biol Chem 274 5 2858 2865 10.1074/jbc.274.5.2858 1:CAS:528:DyaK1MXpsVeluw%3D%3D 9915821 (Pubitemid 29075370)
9. N.H. Park I.H. Song Y.H. Chung 2006 Chronic hepatitis B in hepatocarcinogenesis Postgrad Med J 82 970 507 515 10.1136/pgmj.2006.047431 1:CAS:528:DC%2BD28XpsFKisr0%3D 16891440 (Pubitemid 44258625)
10. Y.F. Liaw 2002 Therapy of chronic hepatitis B: current challenges and opportunities J Viral Hepat 9 6 393 399 10.1046/j.1365-2893.2002.00388.x 12431200 (Pubitemid 35375254)
11. M.A. Sells M.L. Chen G. Acs 1987 Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA Proc Natl Acad Sci U S A 84 4 1005 1009 10.1073/pnas.84.4.1005 1:CAS:528: DyaL2sXhvV2qt7c%3D 3029758 (Pubitemid 17031557)
12. J. Xu J. Wang F. Deng, et al. 2008 Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro Antiviral Res 78 3 242 249 1:CAS:528:DC%2BD1cXktFClu7s%3D 18313149
13. J. Li H. Huang M. Feng, et al. 2008 In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L Antiviral Res 79 2 114 120 10.1016/j.antiviral.2008.03.001 1:CAS:528:DC%2BD1cXmtlWisro%3D 18423640
14. C.J. Chen H.I. Yang J. Su, et al. 2006 Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 1 65 73 10.1001/jama.295.1.65 1:CAS:528:DC%2BD28XhtlKqtQ%3D%3D 16391218 (Pubitemid 43042691)
15. U.H. Iloeje H.I. Yang J. Su, et al. 2006 Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 3 678 686 10.1053/j.gastro.2005.11.016 16530509 (Pubitemid 43374518)
16. H.I. Yang S.N. Lu Y.F. Liaw, et al. 2002 Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 347 3 168 174 10.1056/NEJMoa013215 1:CAS:528:DC%2BD38Xlt12jsLw%3D 12124405 (Pubitemid 34764820)
17. Y. Hoshida 2009 Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence J Hepatol 51 5 842 844 10.1016/j.jhep.2009.08.003 19748698
18. C.F. Wu M.W. Yu C.L. Lin, et al. 2008 Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men Carcinogenesis 29 1 106 112 10.1093/carcin/bgm252 1:CAS:528:DC%2BD1cXhs1aitLY%3D 17999990 (Pubitemid 351201748)
19. B.J. McMahon 2009 The natural history of chronic hepatitis B virus infection Hepatology 49 5Suppl S45 S55 1:CAS:528:DC%2BD1MXlvFKqsL8%3D 19399792
20. G. Chen W. Lin F. Shen, et al. 2006 Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study Am J Gastroenterol 101 8 1797 1803 10.1111/j.1572-0241.2006.00647.x 16817842 (Pubitemid 44166589)
21. Q. Tong Y. Wu D. Luo 2007 Distribution of hepatitis B virus genotypes and its clinical significance in Hubei province, China J Huazhong Univ Sci Technol Med Sci 27 3 274 277 10.1007/s11596-007-0314-8 1:CAS:528:DC%2BD2sXhtFKju7vP 17641840
22. C.R. Howard 1995 The structure of hepatitis B envelope and molecular variants of hepatitis B virus J Viral Hepat 2 4 165 170 10.1111/j.1365-2893. 1995.tb00024.x 1:STN:280:DyaK28%2FptFehtA%3D%3D 7489342
23. P. Arbuthnot S. Carmona A. Ely 2005 Exploiting the RNA interference pathway to counter hepatitis B virus replication Liver Int 25 1 9 15 10.1111/j.1478-3231.2004.0966.x 1:CAS:528:DC%2BD2MXisFCqtrc%3D 15698393 (Pubitemid 40298239)
24. M. Shamay O. Barak G. Doitsh, et al. 2002 Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription J Biol Chem 277 12 9982 9988 10.1074/jbc.M111354200 1:CAS:528:DC%2BD38XisVyltr8%3D 11788598 (Pubitemid 34968106)
25. H. Tang K.E. Banks A.L. Anderson, et al. 2001 Hepatitis B virus transcription and replication Drug News Perspect 14 6 325 334 1:CAS:528:DC%2BD3MXotVWgtb8%3D 12813595
26. Y.C. Chou M.W. Yu C.F. Wu, et al. 2008 Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma Gut 57 1 91 97 10.1136/gut.2006.114066 1:CAS:528:DC%2BD1cXitVKqtrc%3D 17502344
27. J.A. Kwon H.M. Rho 2002 Hepatitis B viral core protein activates the hepatitis B viral enhancer II/pregenomic promoter through the nuclear factor kappaB binding site Biochem Cell Biol 80 4 445 455 10.1139/o02-133 1:CAS:528:DC%2BD38XntVSjurk%3D 12234098